Objectives To address concerns related to the safety profile of both Food and Drug
Administration (FDA)–approved and non–FDA-approved intranasal corticosteroid (INCS) …

Objectives To address concerns related to the safety profile of both Food and Drug
Administration (FDA)–approved and non-FDA-approved intranasal corticosteroid (INCS) use …

Abstract Purpose of Review Intranasal corticosteroid sprays have been available as over-the-
counter (OTC) medications since 2013. As such, clinicians need to be up-to-date with the …

Objectives The safety and efficacy of intranasal corticosteroids (INCS) are well established,
but there remains apprehension that INCS could lead to systemic side effects, as with oral …

Objective: The purpose of this scholarly review is to present an update of the efficacy, safety,
and distribution of intranasal corticosteroids (INCS) in the context of treatment for chronic …

Background In the specialty of Otolaryngology–Head and Neck Surgery, intranasal
corticosteroids are the mainstay treatment for inflammatory processes within the nasal cavity …

Background: Intranasal corticosteroids (INCS) are prescribed for the long-term prophylactic
treatment of inflammatory upper airway conditions. Although some systemic absorption can …

Background Intranasal corticosteroids (INCS) are used in the management of sinonasal
conditions. Use of exogenous steroids can be associated with hypothalamic‐pituitary …

Background Guidelines from throughout the world recommend intranasal corticosteroids
(INSs) as first-line treatment for most patients with moderate to severe allergic rhinitis. In …

Objective Intranasal corticosteroids (INCSs) are widely utilized for the treatment of allergic
rhinitis. Epistaxis is a known adverse effect of INCSs, but it is not known if the risk of epistaxis …